OncoSil Medical Limited (ASX:OSL)
Australia
· Delayed Price · Currency is AUD 0.0040
0.00 (0.00%)
Apr 24, 2025, 4:10 PM AEST
OncoSil Medical Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Net Income | -12.6 | -11.91 | -11.34 | -10.73 | -10.43 | -4.26 | Upgrade
|
| Depreciation & Amortization | -0.03 | 0.04 | 0.18 | 0.19 | 0.18 | 0.15 | Upgrade
|
| Stock-Based Compensation | 0.62 | 0.62 | 0.39 | 0.59 | -0.14 | -2.39 | Upgrade
|
| Other Operating Activities | -1.12 | -0.07 | -0 | 0.09 | 0.11 | -0 | Upgrade
|
| Change in Accounts Receivable | 0.05 | 0.05 | -0.38 | 0.27 | -0.03 | - | Upgrade
|
| Change in Accounts Payable | 0.47 | 0.47 | -0.08 | -0.07 | -0.05 | 1.01 | Upgrade
|
| Change in Other Net Operating Assets | -0.01 | -0.01 | -0.08 | -0.46 | 1.54 | 1.04 | Upgrade
|
| Operating Cash Flow | -12.63 | -10.82 | -11.32 | -10.11 | -8.82 | -4.46 | Upgrade
|
| Capital Expenditures | -0.21 | -0.2 | -0.06 | -0.01 | -0.05 | -0.02 | Upgrade
|
| Investing Cash Flow | -0.21 | -0.2 | -0.06 | -0.01 | -0.05 | -0.02 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 0.03 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 0.03 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.03 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.06 | -0.19 | -0.16 | -0.12 | -0.12 | Upgrade
|
| Total Debt Repaid | 0.07 | -0.06 | -0.19 | -0.16 | -0.15 | -0.12 | Upgrade
|
| Net Debt Issued (Repaid) | 0.07 | -0.06 | -0.19 | -0.16 | -0.15 | -0.09 | Upgrade
|
| Issuance of Common Stock | 9.24 | 3.59 | 6.97 | 9.32 | 0.26 | 19.04 | Upgrade
|
| Other Financing Activities | 7.08 | 2.6 | 2.71 | - | - | -1.16 | Upgrade
|
| Financing Cash Flow | 16.4 | 6.13 | 9.49 | 9.16 | 0.11 | 17.79 | Upgrade
|
| Net Cash Flow | 3.57 | -4.89 | -1.89 | -0.96 | -8.76 | 13.31 | Upgrade
|
| Free Cash Flow | -12.84 | -11.02 | -11.37 | -10.12 | -8.87 | -4.48 | Upgrade
|
| Free Cash Flow Margin | -672.26% | -704.07% | -775.06% | -951.30% | -683.14% | -161.98% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Cash Interest Paid | - | 0 | 0.01 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Cash Income Tax Paid | - | -1.1 | -0.82 | -0.83 | -2.76 | -3.72 | Upgrade
|
| Levered Free Cash Flow | -7.9 | -6.53 | -7.14 | -6.3 | -5.14 | -3 | Upgrade
|
| Unlevered Free Cash Flow | -7.9 | -6.53 | -7.14 | -6.28 | -5.13 | -2.98 | Upgrade
|
| Change in Net Working Capital | 0.63 | -0.5 | 0.56 | 0.45 | -1.46 | -2.05 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.